BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nierhaus A, Berlot G, Kindgen-Milles D, Müller E, Girardis M. Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis. Ann Intensive Care 2020;10:132. [PMID: 33026597 DOI: 10.1186/s13613-020-00740-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Rahmel T, Kraft F, Haberl H, Achtzehn U, Brandenburger T, Neb H, Jarczak D, Dietrich M, Magunia H, Zimmer F, Basten J, Landgraf C, Koch T, Zacharowski K, Weigand MA, Rosenberger P, Ullrich R, Meybohm P, Nierhaus A, Kindgen-milles D, Timmesfeld N, Adamzik M. Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study. Crit Care 2022;26:204. [DOI: 10.1186/s13054-022-04059-0] [Reference Citation Analysis]
2 Lehman KD. Evidence-based updates to the 2021 Surviving Sepsis Campaign guidelines. The Nurse Practitioner 2022;47:24-30. [DOI: 10.1097/01.npr.0000884868.44595.f6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Immohr MB, Böttger C, Aubin H, Westenfeld R, Oehler D, Bruno RR, Dalyanoglu H, Tudorache I, Akhyari P, Lichtenberg A, Boeken U. IgM-enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices. ESC Heart Fail 2022. [PMID: 35854478 DOI: 10.1002/ehf2.14074] [Reference Citation Analysis]
4 Langi Sasongko P, van Kraaij M, So-Osman C. Using a scenario approach to assess for the current and future demand of immunoglobulins: An interview and literature study from The Netherlands. Transfus Med 2022. [PMID: 35751376 DOI: 10.1111/tme.12889] [Reference Citation Analysis]
5 Wu M, Huang Z, Huang W, Lin M, Liu W, Liu K, Li C. microRNA-124-3p attenuates myocardial injury in sepsis via modulating SP1/HDAC4/HIF-1α axis. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-021-00763-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ruiz-Rodriguez JC, Plata-Menchaca EP, Chiscano-Camón L, Ruiz-Sanmartin A, Pérez-Carrasco M, Palmada C, Ribas V, Martínez-Gallo M, Hernández-González M, Gonzalez-Lopez JJ, Larrosa N, Ferrer R. Precision medicine in sepsis and septic shock: From omics to clinical tools. World J Crit Care Med 2022; 11(1): 1-21 [DOI: 10.5492/wjccm.v11.i1.1] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Abram N, Baretta V, Mercolini F, De Bortoli M, Chinello M, Balter R, Bonetti E, Zaccaron A, Vitale V, Caddeo G, Mauro M, Battisti L, Tridello G, Cesaro S. Outcome and Risk Factors of Febrile Episodes Treated with Broad Spectrum Antibiotics and Polyclonal IgM–Enriched Immunoglobulin in Pediatric Oncology Hematology Patients: A Retrospective Study. J Pediatr Infect Dis 2022;17:040-7. [DOI: 10.1055/s-0041-1741122] [Reference Citation Analysis]
8 Bohländer F, Weißmüller S, Riehl D, Gutscher M, Schüttrumpf J, Faust S. The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin. Biomedicines 2021;9:1828. [PMID: 34944644 DOI: 10.3390/biomedicines9121828] [Reference Citation Analysis]
9 Scarpati G, Baldassarre D, Tripepi G, Boffardi M, Piazza O. Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers. Front Pharmacol 2021;12:717349. [PMID: 34566642 DOI: 10.3389/fphar.2021.717349] [Reference Citation Analysis]
10 Coloretti I, Berlot G, Busani S, De Rosa FG, Donati A, Forfori F, Grasselli G, Mirabella L, Tascini C, Viale P, Girardis M. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med 2021;10:3500. [PMID: 34441796 DOI: 10.3390/jcm10163500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Corona A, Richini G, Simoncini S, Zangrandi M, Biasini M, Russo G, Pasqua M, Santorsola C, Gregorini C, Giordano C. Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion. Antibiotics (Basel) 2021;10:930. [PMID: 34438980 DOI: 10.3390/antibiotics10080930] [Reference Citation Analysis]
12 Tabarsi P, Hashemian SMR, Bauhofer A, Savadkoohi AA, Ghadimi S, Haseli S, Dastan F. IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients. Int Immunopharmacol 2021;99:107998. [PMID: 34315117 DOI: 10.1016/j.intimp.2021.107998] [Reference Citation Analysis]
13 Joshi D, Sharma K, Thangasami S, Patel R, Patel I. "Impact of pentaglobin in severe COVID 19 pneumonia- a prospective study.". Int Immunopharmacol 2021;99:107968. [PMID: 34304002 DOI: 10.1016/j.intimp.2021.107968] [Reference Citation Analysis]
14 Liu J, Chen Y, Li R, Wu Z, Xu Q, Li Z, Annane D, Feng H, Huang S, Guo J, Zhang L, Ye X, Zhu W, Du H, Liu Y, Wang T, Chen L, Wen Z, Teboul JL, Chen D. Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study. Clin Microbiol Infect 2021:S1198-743X(21)00234-2. [PMID: 34020032 DOI: 10.1016/j.cmi.2021.05.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Jarczak D, Kluge S, Nierhaus A. Sepsis-Pathophysiology and Therapeutic Concepts. Front Med (Lausanne) 2021;8:628302. [PMID: 34055825 DOI: 10.3389/fmed.2021.628302] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 31.0] [Reference Citation Analysis]
16 Immohr MB, Akhyari P, Aubin H, Westenfeld R, Mehdiani A, Bruno RR, Sipahi NF, Erbel-Khurtsidze S, Reinecke P, Tudorache I, Lichtenberg A, Boeken U. Treatment of donor-specific antibody-mediated rejection after heart transplantation by IgM-enriched human immunoglobulin. ESC Heart Fail 2021;8:3413-7. [PMID: 33969938 DOI: 10.1002/ehf2.13409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Berlot G, Scamperle A, Istrati T, Dattola R, Longo I, Chillemi A, Baronio S, Quarantotto G, Zanchi S, Roman-Pognuz E, Bixio M, Tomasini A. Kinetics of Immunoglobulins in Septic Shock Patients Treated With an IgM- and IgA-Enriched Intravenous Preparation: An Observational Study. Front Med (Lausanne) 2021;8:605113. [PMID: 33732713 DOI: 10.3389/fmed.2021.605113] [Reference Citation Analysis]
18 Busani S, Roat E, Tosi M, Biagioni E, Coloretti I, Meschiari M, Gelmini R, Brugioni L, De Biasi S, Girardis M. Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol. Front Med (Lausanne) 2021;8:616511. [PMID: 33681248 DOI: 10.3389/fmed.2021.616511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Anwar MM. Immunotherapies and COVID-19 related Neurological manifestations: A Comprehensive Review Article. J Immunoassay Immunochem 2020;41:960-75. [PMID: 33393415 DOI: 10.1080/15321819.2020.1865400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]